Immutep IMMP
NASDAQ IMMP
$3.56 +0.10 (+2.89%)
As of: Nov 11, 2026 · 3:59 PM EST

Immutep (IMMP) EBITDA (2013 - 2017)

Updated

Immutep (IMMP) reported EBITDA of -$56.12 million for the quarter ended Jun 30, 2026.

Analysis

Immutep (IMMP) EBITDA (2013 - 2017) Analysis & Trends

For the year ended Jun 30, 2026, Immutep posted EBITDA of -$54.55 million.

  • By year, EBITDA came in at -$37.84 million in the year ended Jun 30, 2025, -$26.68 million in the year ended Jun 30, 2024, -$25.3 million in the year ended Jun 30, 2023 and -$23.14 trillion in the year ended Jun 30, 2022.
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly EBITDA in data going back to the quarter ended Jun 30, 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 8.16 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.99 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 4.20 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 7.05 Bn
10 Immutep 252.65 Mn 41.62 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 1.16 Mn
Mar 31, 2017 -2.11 Mn
Jun 30, 2016 -266,840.83
Mar 31, 2016 -2.33 Mn
Jun 30, 2015 -24.65 Mn
Jun 30, 2014 -12.01 Mn
Jun 30, 2013 -19.56 Mn
API Access

Immutep EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=IMMP&period=max&api_key=YOUR_API_KEY